Bavarian Nordic AS (CHIX:BAVAC) ROCE %: 0.75% (As of Mar. 2026)


CHIX:BAVAC Bavarian Nordic AS CHIX:BAVAC
84 GF Score
Price kr188.30
GF Value kr175.27
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Bavarian Nordic AS ROCE %?

Bavarian Nordic AS CHIX:BAVAC 84 ROCE % is 0.75% as of Mar. 2026. GuruFocus rates CHIX:BAVAC with a GF Score™ of 84/100 and a GF Value™ of kr175.27 (Fairly Valued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bavarian Nordic AS's annualized ROCE % for the quarter that ended in Mar. 2026 was 0.75%.

Bavarian Nordic AS  (CHIX:BAVAc) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bavarian Nordic AS ROCE % Related Terms

Bavarian Nordic AS ROCE % Historical Data

* Premium members only.

The historical data trend for Bavarian Nordic AS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bavarian Nordic AS ROCE % Chart

Bavarian Nordic AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.36 -2.09 14.66 9.06 14.52

Bavarian Nordic AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.21 12.50 36.57 0.91 0.75
CHIX:BAVAC
84GF Score
Bavarian Nordic AS CHIX:BAVAC
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bavarian Nordic AS ROCE % Calculation

Bavarian Nordic AS's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=1812.137/( ( (14405.864 - 2797.008) + (14954.537 - 1597.524) )/ 2 )
=1812.137/( (11608.856+13357.013)/ 2 )
=1812.137/12482.9345
=14.52 %

Bavarian Nordic AS's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=98.916/( ( (14954.537 - 1597.524) + (14102.189 - 922.374) )/ 2 )
=98.916/( ( 13357.013 + 13179.815 )/ 2 )
=98.916/13268.414
=0.75 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.75% mean?
Bavarian Nordic AS (CHIX:BAVAC) has a ROCE % of 0.75% as of Mar. 2026.
Is Bavarian Nordic AS's ROCE % too high?
Bavarian Nordic AS's current ROCE % is 0.75%. Overall, Bavarian Nordic AS has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's ROCE % compare to VRTX and REGN?
Bavarian Nordic AS's ROCE % of 0.75% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Bavarian Nordic AS's current ROCE % is 0.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Based on GuruFocus' analysis, Bavarian Nordic AS (CHIX:BAVAC) is currently considered Fairly Valued. The stock's GF Value™ is kr175.27, compared to a current price of kr188.30 — trading 7.4% above its estimated fair value. The current ROCE % is 0.75%. Bavarian Nordic AS's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Bavarian Nordic AS (CHIX:BAVAC), the current ROCE % is 0.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bavarian Nordic AS (CHIX:BAVAC) Overvalued in 2026?

Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued. The current stock price of kr188.30 is trading 7.4% above its estimated GF Value™ of kr175.27. GuruFocus considers Bavarian Nordic AS to be Fairly Valued.

Key valuation signals for CHIX:BAVAC:

  • ROCE %: 0.75%
  • GF Value™: kr175.27 vs. price of kr188.30 (7.4% above fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the CHIX:BAVAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bavarian Nordic AS Business Description

Address Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
84GF Score

Get the complete analysis for CHIX:BAVAC

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr188.30
Price
kr175.27
GF Value